FLUTICASONE PROPIONATE Recall D-0202-2024
Description: Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-9320-32
FLUTICASONE PROPIONATE Recall D-0202-2024 Information
Status | Completed |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0202-2024 |
Event ID | 89450 |
Brand | WIXELA INHUB |
Generic Name | FLUTICASONE PROPIONATE AND SALMETEROL |
Manufacturer | FLUTICASONE PROPIONATE AND SALMETEROL |
Original Package? | 1 |
Active Substance | FLUTICASONE PROPIONATE SALMETEROL XINAFOATE |
Drug Route | RESPIRATORY (INHALATION) |
Distribution | Nationwide USA |
Quantity | 1 unit |
Recall Reason | CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. |
Drug Classification | Class II |
Drug Code Info | 20240103 |
Product NDC | 0378-9320 0378-9321 0378-9322 |
Recall Initiation Date | 20220126 |
Report Date | 20240103 |
Classification Date | 20231226 |
Address | 7200 Cardinal Pl W Dublin, OH 43017-1094 United States |
Recalling Firm | CARDINAL HEALTHCARE |
Initial Notification | Letter |
Unique Ingredient Identifier | O2GMZ0LF5W 6EW8Q962A5 |
Drug Application Number | ANDA208891 |
Structured Product Labeling (SPL ID) | 03d33612-03b4-4a2c-ba86-47816db363ce |
Structured Product Labeling (SPL Set ID) | 3beef422-8a07-4a45-9ba6-414511e4b7e2 |
Similar To |